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ABSTRACT 
 
Objectives The potential role of surgery-
induced pro-inflammatory cytokines on the 
development of tumor recurrence in 
pancreatic cancer was investigated. 
 
Main outcome measures The adhesion of 3 
human pancreatic carcinoma cell lines, 
PanC1, MiaPaCa and BxPC3 to monolayers 
of microvascular endothelial cells after pre-
incubation with 0.1 or 10 ng/mL IL-1beta, 
TNF-alpha or IL-6 was assessed in a 
reproducible human in vitro assay. Untreated 
monolayers served as controls. 
 
Results Pre-incubation of microvascular 
endothelial cells with IL-1beta or TNF-alpha, 
but not IL-6, increased adhesion of all three 
tumor cell lines as compared to adhesion in 
the control group. Maximally stimulated 
adhesion for PanC1 reached 159%, for 
MiaPaCa 204% and for BxPC3 155% (all vs. 
the control, P<0.001). Pre-incubation of 
microvascular endothelial cells with IL-1beta 
or TNF-alpha resulted in a significant up-
regulation of E-selectin, ICAM-1 and 
VCAM-1 expression. The addition of anti-E-
selectin, anti-ICAM-1 or anti-VCAM-1 
monoclonal antibodies did not decrease 
adhesion to microvascular endothelial cells 
pre-incubated with IL-1beta. Therefore, 
enhanced tumor cell binding seems to be 
independent of these adhesion molecules. 
 
Conclusions Pro-inflammatory cytokines 
derived from surgical trauma may enhance 
tumor cell adhesion to microvascular 
endothelial cells and thus bring about more 
successful tumor cell implantation resulting in 
an increased risk of metastasis formation. 
 
 
INTRODUCTION 
 
In the western world, pancreatic cancer leads 
to approximately 150,000 deaths each year, 
making it one of the five leading causes of 
cancer-related deaths [1]. Potential curative 
resection is still the only option that offers a 
chance for cure in pancreatic cancer patients, 
but this can only be performed in about 10-
15% of pancreatic cancer patients [2]. the 
prognosis for these patients is still poor, since 
more than 80% die within 5 years after 
surgery. Recurrences are found locally, in the 
intra-abdominal cavity (peritoneal and 
hepatic) and to a lesser extent at extra-
abdominal sites [3]. 
Hematogenous metastasis develops from 
circulating tumor cells. These cells can be 
detected in 60-80% of pancreatic cancer 
patients and this percentage increases during 
surgical procedures [4, 5, 6]. 
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Operative trauma in the tissue itself may favor 
development of tumor recurrence. An 
association between surgical trauma and 
tumor recurrence has been supported by 
previous in vivo and in vitro studies [7, 8, 9, 
10, 11, 12]. These studies showed that 
surgical trauma brings about enhanced 
locoregional tumor recurrence by the 
inflammatory reaction it provokes. The 
inflammatory reaction is not confined locally, 
but spreads out systemically as well, yet to a 
somewhat lesser degree [13, 14, 15, 16, 17]. 
Indeed, in several in vivo studies, surgical 
trauma enhanced tumor recurrence at distant 
sites as well [18, 12]. 
The inflammatory reaction provoked by 
surgical trauma leads to the activation of 
leukocytes and monocytes with the release of 
pro-inflammatory cytokines and reactive 
oxygen species. Thus, it has been found that, 
after major abdominal surgery, the pro-
inflammatory cytokines interleukin-6 (IL-6), 
interleukin-1beta (IL-1beta) and tumor 
necrosis factor-alpha (TNF-alpha) in the 
peripheral blood are elevated [13, 14, 15, 16, 
17]. 
The adhesion of circulating tumor cells to the 
microvascular endothelium of organs at 
distant sites - like the liver and the lungs - is 
an important step in blood-borne metastasis. 
In previous in vitro experiments we showed 
that pro-inflammatory cytokines are capable 
of enhancing the adhesion of human colon 
carcinoma cells to the microvascular 
endothelium, most likely by the up-regulation 
of adhesion molecules to the endothelium 
[11]. 
In this study, we investigated the influence of 
the pro-inflammatory cytokines IL-1beta, 
TNF-alpha and IL-6 on the adhesion of 
human pancreatic carcinoma cells to 
microvascular endothelial cells. Therefore, a 
reproducible human in vitro model was 
developed. Moreover, the expression of cell 
adhesion molecules on both endothelial and 
tumor cells was assessed as well as the 
influence of blocking antibodies to cell 
adhesion molecules in tumor cell adhesion 
assays. 
 
MATERIALS AND METHODS 
 
Cells 
 
Human microvascular endothelial cells 
(MECs) at passage 4 were purchased from 
Cambrex (Verviers, Belgium) and maintained 
in EGM-2-MV Bullet kit according to the 
manufacturer’s instructions at 37°C, 95% 
relative humidity and 5% CO2. Confluent 
monolayers were passaged by trypsin/EDTA 
(0.025%/0.01%) and cells were used up to 
passage 8. 
The human pancreatic carcinoma cell lines 
PanC1, MiaPaCa and BxPC3 were also grown 
in an EGM-2-MV Bullet kit in order to create 
similar culture conditions to the endothelial 
cells, which was necessary for the 
experiments. The tumor cells were maintained 
by serial passage after trypsinization using 
trypsin/EDTA (0.05% 0.02%) (all, except 
penicillin, obtained from Gibco, Breda, the 
Netherlands; penicillin from Yamanouchi, 
Leiderdorp, the Netherlands). Before the 
adhesion assay, tumor cells were harvested 
using trypsin and maintained in suspension 
culture for two hours to regenerate cell-
surface proteins. 
 
Adhesion Assay 
 
To quantify tumor cell adhesion to MECs, a 
standardized cell adhesion assay was 
developed according to the methods of 
Catterall et al . [19]. Briefly, endothelial 
monolayers were established in 96 well 
microtiter plates (Perkin Elmer, Groningen, 
the Netherlands). To do this, confluent cells 
were trypsinized and 2x104 endothelial cells 
were added to each well. 
The plates were incubated at 37°C, 95% 
relative humidity, 5% CO2 and the medium 
was replaced daily by fresh medium. The 
MECs reached confluence in 3 to 4 days as 
determined by light microscopy. 
To determine the effect of cytokines on tumor 
cell adhesion, endothelial monolayers were 
pre-incubated with 0.1 or 10 ng/mL 
recombinant human IL-1beta, TNF-alpha and  
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IL-6 (R&D Systems, Uithoorn, The 
Netherlands) for 4 or 12 hours. Untreated 
monolayers served as controls. Not only was 
the effect of the endothelial pre-incubation 
investigated but the effect of tumor cell pre-
incubation as well. Therefore, BxPC3 cells 
were pre-incubated with 10 ng/mL IL-1beta 
for 12 hours before the adhesion assay. 
To quantify tumor cell adhesion, the tumor 
cells were labeled with calcein-AM 
(Molecular Probes, Leiden, the Netherlands) 
for 45 minutes, washed 3 times and added to 
the wells (3x104 per well). The plates were 
centrifuged for 1 minute at 80 g in a Heraeus 
centrifuge (Etten Leur, the Netherlands) and 
incubated at 37°C for 1 hour. Thereafter, the 
wells were washed twice with medium to 
remove non-adherent tumor cells. The 
remaining fluorescence per well was 
measured on a Perkin Elmer (Gouda, the 
Netherlands) plate reader using 485 nm 
excitation and 530 nm emission filters. 
 
Immunocytochemistry 
 
Endothelial and tumor cells were prepared for 
staining by cytospin preparation, fixed in 
acetone for 10 minutes and stored at -20°C 
until used. 
The cytospins were incubated for 30 minutes 
at room temperature with the following 
primary antibodies: mouse anti-human 
monoclonal antibodies to E-selectin (R&D 
Systems, Uithoorn, The Netherlands), ICAM-
1, VCAM-1 (Dako Cytomation Heverlee, 
Belgium), sialyl Lewis a (sLea), sialyl Lewis 
x (sLex) (Sanbio, Uden, the Netherlands), 
lymphocyte function-associated antigen-1 
(LFA-1) (alphaLbeta2) and very late 
activation antigen-4 (VLA-4) (alpha4beta1) 
(Becton Dickinson, Alphen a/d Rijn, the 
Netherlands). Negative controls were 
incubated with PBS. As secondary antibodies, 
biotinylated goat anti-mouse antibodies were 
used followed by incubation with 
streptavidin-biotinylated alkalin-phosphatase 
complex. Substrate development was carried 
out with new fuchsin 4%. The cytospins were 
counterstained with hematoxylin. 
The expression of cell adhesion molecules 
was quantified by two different observers 
using semi-quantitative scoring system 
ranging from no expression (-), weakly 
positive (±) to positive expression (+). 
 
Enzyme Immuno Assay (EIA) 
 
Endothelial cells and tumor cells were grown 
to confluence as described for the adhesion 
assays in 96-well flat-bottomed multititer 
plates (Becton Dickinson, Alphen a/d Rijn, 
the Netherlands). The endothelial cells were 
pre-incubated with either cell culture media 
alone or with media containing IL-1beta, 
TNF-alpha or IL-6 (0.1 and 10 ng/mL). The 
tumor cells were pre-incubated with either 
cell culture media alone or with media 
containing IL-1beta or TNF-alpha (10 
ng/mL). Following this pre-incubation, the 
cells were washed with phosphate buffered 
saline (room temperature, pH 7.4), fixed in 
ethanol/methanol for 45 minutes and then 
washed again. Subsequently, the wells were 
incubated for 10 minutes with 1% goat serum 
to block unspecific binding sites. Mouse 
monoclonal antibody to E-selectin, ICAM-1, 
VCAM-1 (R&D Systems, Uithoorn, The 
Netherlands) sLea, sLex (Sanbio, Uden, the 
Netherlands), LFA-1 (alphaLbeta2) or VLA-4 
(alpha4beta1) (Becton Dickinson, Alphen a/d 
Rijn, the Netherlands) was added for 1 hour, 
followed by the addition of a second 
antibody, biotinylated goat anti-mouse 
antibody (Sigma Zwijndrecht, the 
Netherlands) in a dilution of 1:250. Increased 
sensitivity was obtained using the ExtrAvidin-
Peroxidase system (Sigma, Zwijndrecht, the 
Netherlands). Adding 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) 
diammonium salt in citrate-phosphate buffer 
with urea hydrogen peroxide-developed 
substrate. Incubation of the endothelial cells 
without the primary antibody served as a 
negative control. As a positive control, the 
ExtrAvidin-Peroxidase (Sigma, Zwijndrecht, 
the Netherlands) system was added followed 
by substrate development without washing 
away the peroxidase. After 40 minutes, the  
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reaction was stopped with sodium fluoride 
and photometrical evaluation was performed 
with computer-controlled ELISA reader at a 
lambda equal to 405 nm. 
 
Function Blocking Assay 
 
Endothelial monolayers were pre-incubated 
with 10 ng/mL IL-1beta for 12 hours. One 
hour before the adhesion assay was 
performed, 50 g/mL of function blocking 
monoclonal mouse antibodies to human E-
selectin (R&D Systems, Uithoorn, The 
Netherlands) were then added to the 
endothelial monolayers. The same inhibition 
assays were carried out with monoclonal 
mouse antibodies to human ICAM-1 (25 
g/mL) and VCAM-1 (60 g/mL) (R&D 
Systems, Uithoorn, The Netherlands) (the 
concentration of the antibody was in 
accordance with the instructions of the 
manufacturer). 
 
STATISTICS 
 
Data are reported as mean±SD values. The 
data were analyzed using one- or two-way 
analysis of variance (ANOVA) according to 
the experimental design applied. The simple 
and the repeated contrasts were applied to 
ANOVA in order to compare the various 
experiments with the control experiment as 
well as adjacent categories, respectively. The 
effects within specific categories were 
evaluated using nested designs. The SPSS 
version 13.0 for Windows was used to 
analyze the data. Two-tailed P values less 
than 0.05 were considered to be statistically 
significant. Experiments (n=6) were 
performed at least twice with comparable 
results while quadriplate wells were used in 
the EIA assays. 
 
RESULTS 
 
Validation of Assay 
 
Labeling tumor cells with calcein-AM did not 
decrease their viability (greater than 95% 
using trypan blue). To determine the stability 
of calcein labeling, the fluorescence of the 
labeled cells and of the supernatant of the 
labeled cells was measured. The fluorescence 
of the labeled cells remained constant for at 
least 60 minutes indicating retention of the 
dye within the cells (data not shown). This 
Comparisons between 4- and 12-hour pre-incubation times (the time factor was evaluated within the various categories using a nested design): 
aP=0.352, bP<0.001, cP=0.003, 
dP=0.023, eP=0.191, fP=0.129. 
aP=0.712, bP=0.001, cP=0.420, 
dP=0.139, eP=0.441, fP=0.302. 
aP=0.577, bP<0.001, cP=0.065, 
dP=0.127, eP=0.079, fP=0.001. 
Figure 1. Adhesion of PanC1, MiaPaCa and BxPC3 to MECs after 4 and 12 hours of pre-incubation of MECs with 0.1 
or 10 ng/mL IL-1beta, TNF-alpha or IL-6. Mean±SD values are shown. Generally, n=6 samples were evaluated for 
each experiment. (Two-way ANOVA). Black P values refer to the comparison with the control group (untreated 
MECs): simple contrast was applied within the two time evaluations by a nested design. Red P values refer to the 
comparison between 0.1 and 10 ng/mL; repeated contrast was applied within the two time evaluations using a nested 
design. 
JOP. J Pancreas (Online) 2006; 7(5):454-464. 
JOP. Journal of the Pancreas - http://www.joplink.net - Vol. 7, No. 5 - September 2006. [ISSN 1590-8577] 458 
result was also seen in the adhesion assay, 
where maximal tumor cell adhesion was 
reached after a one hour incubation followed 
by a decrease at longer incubation times (data 
not shown). Therefore, for all subsequent 
experiments, the incubation time was 1 hour. 
Dilution series with labeled tumor cells on 
MEC monolayers showed a linear correlation 
between cell number and measured 
fluorescence (data not shown) which was 
used as a standard to calibrate the 
fluorescence measured. In this way, the 
amount of adhered tumor cells in the 
experimental wells could be determined. 
 
Adhesion to Endothelial Cells 
 
In all assays, PanC1 cells adhered to untreated 
MEC in a percentage ranging from 10 to 20%, 
i.e. the basal or control adhesion. The basal 
adhesion of BxPC3 ranged from 20 to 30% in 
all assays and that of MiaPaCa ranged from 5 
to 20% 
Pre-incubation of MEC with IL-1beta or 
TNF-alpha, but not with IL-6 resulted in time- 
and concentration-dependent-enhanced tumor 
cell adhesion (Figure 1). Four-hour pre-
incubation with 0.1 ng/mL IL-1beta resulted 
in a significant enhancement of BxPC3 only 
(113% vs. control, P=0.016), while 4-hour 
pre-incubation with 10 ng/mL IL-1beta 
resulted in a significant enhancement for 
MiaPaCa (144% vs. control, P=0.011) and 
BxPC3 (127% vs. control, P<0.001). After a 
4-hour pre-incubation of MEC with TNF-
alpha, adhesion for all 3 cell lines was 
significantly enhanced (PanC1: P=0.004 and 
P=0.010 for 0.1 and 10 ng/mL, respectively; 
MiaPaCa and BxPC3: P<0.001 at each 
concentration). As far as 4-hour pre-
incubation with IL-6 was concerned, only a 
slight enhancement adhesion of MiaPaCa 
(135% vs. control, P=0.039) was obtained 
with 10 ng/mL IL-6. A twelve-hour pre-
incubation with IL-6 did not show any 
significant enhancement of adhesion. The 
enhancement of adhesion for all cell lines was 
significant after 12 hours of pre-incubation 
with 0.1 ng/mL of IL-1beta and the adhesion 
for all cell lines significantly increased by 
increasing the IL-1beta concentration to 10 
ng/mL; for PanC1, adhesion reached 159% 
vs. control (P<0.001), for MiaPaCa it was 
204% (P<0.001) and for BxPC3 it was 127% 
(P<0.001). TNF-alpha resulted in enhanced 
adhesion for all cell lines at 0.1 ng/mL as well 
as at 10 ng/mL, but a significant increase with 
the concentration was observed only for 
BxPC3; for PanC1 it was 155% (P<0.001) 
and 144%(P<0.001), for MiaPaCa 178% 
(P=0.001) and 203% (P<0.001) and for 
BxPC3 144% (P<0.001) and 137% (P<0.001) 
vs. control at 01. and 10 ng/mL TNF-alpha, 
respectively. 
A time-dependent increase in adhesion was 
observed with pre-incubation with 10 ng/mL 
IL-1beta for all three cell lines (P<0.001) as 
well as at the two concentrations (0.1 ng/mL: 
P=0.003; 10 ng/mL: P=0.023) of TNF-alpha 
for PanC1 cells only while a significant 
decrease in adhesion was observed for the 
BxPC3 cell line from 4- to 12-hour pre-
incubation with 10 ng/mL IL-6 (P=0.001). 
Pre-incubation with higher concentrations of 
the pro-inflammatory cytokines (50 and 100 
ng/mL) did not result in a more pronounced 
enhancement of adhesion (data not shown). 
 
The Role of Cell Adhesion Molecules 
 
It is known that both sialyl Lewis a (sLea) and 
sialyl Lewis x (sLex) are ligands for E-
selectin; LFA-1 (alphaLbeta2) is a ligand for 
ICAM-1, and VLA-4 (alpha4beta1) for 
VCAM-1. 
Table 1 shows the expression of cell adhesion 
molecules on untreated MECs, MECs pre-
incubated with 10 ng/mL IL-1beta for 12 
hours, as well as on PanC1, MiaPaCa and 
BxPC3. Untreated MECs express ICAM-1, as 
well as LFA-1 and VLA-4, whereas E-
selectin and VCAM-1 are not expressed. Both 
these adhesion molecules are up-regulated by 
exposure of MECs to IL-1beta. BxPC3 cells 
express all tested adhesion molecules, PanC1 
cells do not express VCAM-1 only, whereas 
MiaPaCa cells selectively express sLea. 
This difference in the adhesion molecule 
pattern is displayed in the percentage of 
adherent cells to MECs, which is highest for  
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BxPC3 and lowest for MiaPaCa (data not 
shown). 
We further evaluated the endothelial cell 
adhesion molecules by EIA (a semi-
quantitative assay) (Figure 2). The staining 
intensity (in optical density units measured at 
405 nm) of E-selectin expression on 
unstimulated MECs was 0.2. Following pre-
incubation with 0.1 and 10 ng/mL IL-1beta 
for 12 hours the staining intensities reached 
0.19 (P=0.739) and 0.50 (P<0.001), 
respectively. Pre-incubation with 0.1 and 10 
ng/mL TNF-alpha significantly up-regulated 
E-selectin expression to a staining intensity of 
0.47 and 0.59, respectively (both P<0.001). 
IL-6 did not up-regulate E-selectin 
expression. ICAM-1 expression was up-
regulated from 0.2 to 0.27 (P<0.001) and to 
0.40 (P<0.001) by pre-incubation with 0.1 and 
10 ng/mL IL-1beta, respectively. Pre-
incubation with 0.1 and 10 ng/mL TNF-alpha 
up-regulated expression to 0.48 (P<0.001) and 
to 0.47 (P<0.001), respectively whereas once 
again IL-6 did not influence expression. A 
slight but significant enhancement in the 
expression of VCAM-1 was induced in all but 
one experiment (the pre-incubation with 0.1 
ng/mL IL-6; P=0.062); maximal induction 
was reached with 10 ng/mL TNF-alpha (from 
0.23 to 0.31; P=0.001). 
Next, we focused in more detail on 
interactions in inhibition assays between 
tumor cells and endothelial cells by using 
monoclonal antibodies against adhesion 
molecules on MECs. None of the function 
blocking antibodies tested significantly 
influenced basal adhesion apart from a slight 
decrease in PanC1 cells with anti-E-selectin 
(Figure 3). Pre-incubation with IL-1beta 
Table 1. Cell adhesion molecules expressed by untreated MECs, MECs pre-incubated with 10 ng/mL IL-1beta (12 h) , 
PanC1, MiaPaCa and BxPC3 as determined by immunocytochemistry. 
Cell adhesion 
molecule 
Untreated MECs 
(control) 
MECs + 
IL-1beta 
PanC1 MiaPaCa BxPC3 
E-selectin - + ± - ± 
ICAM-1 + + + - + 
VCAM-1 - + - - + 
sLea - - + + + 
sLex - - + - + 
LFA-1 + + ± - + 
VLA-4 + + ± - + 
 
Figure 2. Anti-E-selectin, anti-ICAM-1 and anti-
VCAM-1 expression on MECs pre-incubated for 12 
hours with 0.1 and 10 ng/mL TNF-alpha, IL-1beta or 
IL-6 assessed by EIA. Bars represent the mean±SD 
absorbance values (OD 405 nm). Generally, n=4 wells 
were evaluated for each experiment. (One-way 
ANOVA). Black P values refer to the comparison with 
the control group (untreated MECs); simple contrast 
was applied. Red P values refer to the comparison 
between 0.1 and 10 ng/mL; repeated contrast was 
applied. 
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significantly (P<0.001) enhanced adhesion of 
all three cell lines both in the absence or the 
presence of all the antibodies tested. Anti-E-
selectin was not capable of inhibiting the 
enhanced adhesion of all 3 tumor cell lines to 
IL-1beta pre-incubated MECs while slight 
increases of adhesion were observed in PanC1 
cells with anti-ICAM-1 and anti-VCAM-1 
antibodies. No significant modifications were 
found in MiaPaCa cells, while slight 
decreases of adhesion were obtained in 
BxPC3 with anti-ICAM-1 (with and without 
the addition of anti-E-selectin) and anti-
VCAM-1 antibodies. (Figure 3). Furthermore, 
pre-incubation of MECs with TNF-alpha 
instead of IL-1beta gave similar results (data 
not shown). The cell adhesion molecules sLea, 
sLex, LFA-1 and VLA-4 are probably not the 
ligands on MECs responsible for increased 
tumor cell adhesion after exposure to the pro-
inflammatory cytokines. First of all, sLea and 
sLex are neither expressed on MECs or on 
activated MECs and its counterpart E-selectin 
is not expressed on MiaPaCa and only weakly 
expressed on PanC1 and BxPC3 (Table 1). 
Furthermore, although both LFA-1 and VLA-
4 are expressed on MECs and are slightly up-
regulated after exposure to pro-inflammatory 
cytokines (data not shown), their counterparts 
are not expressed on MiaPaCa. However, the 
adhesion of MiaPaCa clearly increased to 
cytokine pre-incubated MECs and, therefore, 
LFA-1 and VLA-4 are unlikely to be the 
adhesion molecules on MEC which induce 
enhanced adhesion. 
 
Exposure of Tumor Cells 
 
Since not only the endothelium but the 
circulating tumor cells as well are exposed to 
factors released during surgery, the influence 
of pro-inflammatory cytokines on adhesion 
molecule expression of the tumor cells was 
investigated subsequently by EIA (Figure 4). 
For PanC-1 the expression of VLA-4 shows a 
slight but significant decrease after IL-1beta 
pre-incubation (P=0.003). The expression of 
LFA-1 on MiaPaCa after IL-1beta pre-
incubation is also slightly decreased 
(P=0.016). On BxPC3 however, a slight but 
significant increase in ICAM-1 (P<0.001) and 
LFA-1 (P=0.049) was observed. Comparable 
results were obtained after pre-incubation of 
the tumor cells with TNF-alpha (data not 
shown). 
Therefore, the influence of exposing BxPC3 
to IL-1beta on tumor cell adhesion was 
Figure 3. Adhesion of PanC1, MiaPaCa and BxPC3 to 
MECs. Prior to tumor cell adhesion, the MECs were 
pre-incubated for 12 hours with 10 ng/mL IL-1beta 
and/or for 1 hour with anti-E-selectin (E-sel), anti-
ICAM-1 (ICAM-1), both anti-E-selectin and anti-
ICAM-1 (E-sel+ICAM-1) or anti-VCAM-1 (VCAM-
1). Mean±SD values are shown. Generally, n=6 
samples were evaluated for each experiment. (One-way 
ANOVA). Black P values refer to the comparisons 
with values observed without added antibodies (either 
untreated MAC or IL-1beta pre-incubated MECs): the 
simple contrast was applied. Red P values refer to the 
comparisons between untreated MAC and IL-1beta 
pre-incubated MEC; repeated contrast was applied. 
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investigated (Figure 5). The overall analysis 
showed that pre-incubation with IL-1beta 
significantly enhanced adhesion (P<0.001) 
while BxPC3 did not (P=0.241). The effect of 
incubation with BxPC3 was not significantly 
related to the presence or absence of pre-
incubation with IL-1beta (interaction term of 
two-way ANOVA: P=0.096). In particular, 
the effect of pre-incubation with BxPC3 was 
not significant either in control MECs 
(P=0.050) or in IL-1beta pre-incubated cells 
(P=0.706) while the effect of pre-incubation 
with IL-1beta was equally significant in 
control (P<0.001) and pre-incubated 
(P<0.001) BxPC3 cells. 
 
DISCUSSION 
 
Previous in vivo studies suggested a tumor-
promoting effect from surgical trauma, not 
only locally, but systemically as well. This 
theory was further explored in a human in 
vitro model, showing that pro-inflammatory 
cytokines, released during surgical trauma, 
enhance the adhesion of human colon 
carcinoma cells to mesothelial cells and 
microvascular endothelial cells [11]. 
Therefore, surgical trauma may enhance 
tumor recurrence loco-regionally as well as at 
distant sites. 
In this human in vitro study, we demonstrated 
that the pro-inflammatory cytokines IL-1beta 
and TNF-alpha significantly enhance the 
adhesion of 3 human pancreatic carcinoma 
cell lines to the microvascular endothelium. 
IL-6, which is distinctly elevated during 
surgical trauma and is an activator of several 
inflammatory mechanisms, did not influence 
Figure 4. Adhesion molecule expression on PanC1, 
MiaPaCa and BxPC3 obtained with EIA. Orange bars 
represent basal expression; green bars represent 
expression after 12 hours pre-incubation with 10 
ng/mL IL-1beta. Bars represent the mean±SD
absorbance values (OD 405 nm). Generally, n=4 wells 
were evaluated for each experiment. (Two-way 
ANOVA; the effect of the pre-incubation with IL-1beta 
was evaluated within the various categories using a 
nested design). 
Figure 5. The effect of the pre-incubation of MECs 
with 10 ng/mL IL-1beta and/or BxPC3. Bars represent 
the mean±SD absorbance values (OD 405 nm). 
Generally, n=6 samples were evaluated for each 
experiment. (Two-way ANOVA: the effects of pre-
incubation with IL-1beta and BxPC3 were evaluated 
within the various categories using a nested design).
Black P values refer to the comparisons with control 
MECs (without IL-1beta pre-incubation). Red P values 
refer to the comparisons between control BxPC3 and 
pre-incubated BxPC3 cells. 
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interactions between tumors and endothelial 
cells. 
In previous studies [11], we excluded the 
possibility that enhanced adhesion after 
cytokine exposure was caused by enhanced 
growth of endothelial cells resulting in a 
higher number of MEC and, consequently, 
more binding receptors since proliferation 
assays did not show enhanced growth of the 
exposed MECs as compared to normal MECs 
during the 12 hour pre-incubation period. 
Interactions between tumor cells and 
endothelial cells are accomplished by 
adhesion molecules. The results of the EIA 
showed that the endothelial adhesion 
molecules E-selectin and ICAM-1 are 
significantly up-regulated after pre-incubation 
with TNF-alpha or IL-1beta. The question 
then arises as to whether the increased tumor 
cell binding is dependent on the up-regulation 
of E-selectin or ICAM-1. VCAM-1 is not 
likely to be the adhesion molecule responsible 
since no significant enhancement in MEC 
expression was found after cytokine pre-
incubation, except for a slight increase after 
pre-incubation with 10 ng/mL TNF-alpha. In 
previous studies, the adhesion of several 
pancreatic carcinoma cell lines to human 
umbilical vein endothelial cells (HUVECs), 
which are macrovascular cells, could be 
inhibited by antibodies against the E-selectin 
adhesion molecule [20, 21]. In these studies 
no inhibition in adhesion to activated 
endothelium was observed using monoclonal 
antibodies against E-selectin. The absence of 
inhibition could not be attributed to the 
malfunctioning of antibodies or technical 
problems since we brought about strong 
inhibition in the adhesion of HT29 colon 
carcinoma cells to activated HUVECs using 
the same protocol and antibodies [11]. 
However, in that particular study, we were not 
able to block the adhesion of HT29 cells to 
MECs. Therefore, it was concluded that 
another adhesion molecule or a complex of 
adhesion molecules was responsible for HT29 
cell interactions with MECs. Again, in this 
study no inhibition could be reached using E-
selectin antibodies in the adhesion of tumor 
cells to MECs. Even for MiaPaCa, with 
limited adhesion options according to 
immunohistochemistry results concerning the 
adhesion molecules tested, i.e. only binding 
through E-selectin on activated MECs with 
sLea on MiaPaCa seemed possible, no 
inhibition was observed using the E-selectin 
antibody, suggesting that another adhesion 
molecule or a complex of adhesion molecules 
seems responsible for the enhanced adhesion 
to MEC. 
Antibodies against other major adhesion 
molecules on MECs, ICAM-1 and VCAM-1, 
did not lead to a reduction in tumor cell 
adhesion to activated MECs either. Thus, both 
colon carcinoma cells and pancreatic 
carcinoma cells seem to exhibit different 
adhesion patterns to macrovascular 
endothelial cells as compared to 
microvascular endothelial cells. In contrast to 
the E-selectin dependent adhesion to 
HUVECs, adhesion to MECs is E-selectin 
independent and formed by another novel 
adhesion molecule or a complex of adhesion 
molecules consisting of more than E-selectin 
and ICAM-1. 
In the systemic inflammatory response during 
and after surgery, the circulating tumor cells - 
like endothelial cells - are exposed to pro-
inflammatory cytokines as well. Therefore, 
the influence of pro-inflammatory cytokines 
regarding adhesion molecule expression on 
the tumor cells was evaluated as well. Only 
ICAM-1 expression on BxPC3 showed a 
slight enhancement after exposure to IL-1beta 
and TNF-alpha; the expression of the other 
adhesion molecules was not affected. These 
rather moderate changes in adhesion molecule 
expression after IL-1beta or TNF-alpha 
exposure might be caused by the already high 
basal adhesion molecule expression on tumor 
tissue as compared to normal tissue [22]. 
Since only BxPC3 showed a difference after 
IL-1beta or TNF-alpha exposure, we 
performed adhesion assays with this cell line. 
However, pre-incubation of BxPC3 with IL-
1beta gave comparable results when 
compared to untreated BxPC3; therefore, in 
this study, no effect of tumor cell exposure to 
pro-inflammatory cytokines was detected. It 
is interesting that tumor cells are capable of 
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producing pro-inflammatory cytokines 
themselves and that these tumoral cytokines 
may influence interactions with the 
microvascular endothelium [23]. 
In conclusion, pro-inflammatory cytokines 
derived from surgical trauma enhance the 
adhesion of these 3 tumor cell lines to MECs. 
In addition, these cytokines increase the 
expression level of several adhesion 
molecules on the cell surface of MECs. The 
inability of function blocking antibodies to E-
selectin, ICAM-1 and VCAM-1 to block 
increased tumor cell adhesion to MECs, 
suggests that other adhesion molecules or 
even a complex of adhesion molecules 
determine this enhanced tumor cell adhesion 
by the pro-inflammatory cytokines which 
were evaluated. 
Although surgery is the cornerstone in the 
treatment of pancreatic cancer and the only 
chance of cure, it may bring about more 
successful tumor cell implantation locally and 
in distant organs resulting in an increased risk 
of metastasis formation. Further studies, 
including in vivo studies, are required to 
unravel the precise mechanisms by which 
surgery enhances the development of distant 
metastases. Ultimately, this may lead to new 
treatment modalities targeting the 
development of post-operative tumor 
development. 
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